Bafna Pharmaceuticals Limited Share Price & Technical Analysis

BAFNAPH · ₹135.8 (+0.60%)

Healthcare / Drug Manufacturers - Specialty & Generic

AI Score 53 · Weak

₹135.8

+0.60%

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences L

Price chart

AI snapshotScore 53/100

Weak · Strong · Uptrend

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

₹3.15B

P/E ratio

32.52

52W high

₹202.1

52W low

₹72.01

Volume

1,390

Beta

0.18

Related stocks in Healthcare

Frequently asked questions

What is Bafna Pharmaceuticals Limited share price today?
Bafna Pharmaceuticals Limited (BAFNAPH) last traded around ₹135.8 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does BAFNAPH have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BAFNAPH. Download the app for real-time alerts.
How can I analyze Bafna Pharmaceuticals Limited stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro